SCHEMBL7380788

SCHEMBL7380788

COc1cc2c(cc1OC)C(c1cc(OC)c(OC)c(OC)c1)C(O)(C(=O)O)OC2=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSD17B10 Q99714 2/20 0.37
CYP1A2 P05177 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
HPGD P15428 1/20 0.36
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
TSHR P16473 1/20 0.35
PAX8 Q06710 1/20 0.35
PTPN1 P18031 1/20 0.35
ACHE P22303 1/20 0.35
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7387564 0.92 MAPK1 (0.41) ALDH1A1KDM4ESMN1; SMN2HSD17B10CYP1A2
SCHEMBL7385552 0.91 ALDH1A1 (0.53) ALDH1A1KDM4ESMN1; SMN2HSD17B10CYP1A2
SCHEMBL7384916 0.90 MAPT (0.40) ALDH1A1KDM4ESMN1; SMN2HSD17B10CYP1A2
SCHEMBL7384620 0.89 MAPT (0.39) ALDH1A1KDM4ESMN1; SMN2HSD17B10CYP1A2
SCHEMBL7376756 0.89 AKR1B1 (0.43) ALDH1A1KDM4ESMN1; SMN2HSD17B10HPGD
SCHEMBL7386139 0.88 KDM4E (0.39) ALDH1A1KDM4EHSD17B10CYP1A2MEN1
SCHEMBL7381140 0.87 ALDH1A1 (0.42) ALDH1A1KDM4ESMN1; SMN2HSD17B10CYP1A2
SCHEMBL7386536 0.86 NFKB1 (0.39) ALDH1A1KDM4EMAPTTSHRTUBB4A
SCHEMBL7383655 0.76 BCHE (0.40) ALDH1A1KDM4ESMN1; SMN2CA2HPGD
SCHEMBL7385028 0.74 AKR1B1 (0.43) ALDH1A1KDM4ESMN1; SMN2HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486155-B1 Method of inhibiting neoplastic cells with isoquinoline derivatives CELL PATHWAYS INC 2002-11-26 US disclosed
WO-1998038168-A1 ISOQUINOLINONE DERIVATIVES, PROCESS FOR PREPARING THE SAME, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS TANABE SEIYAKU CO., LTD. (JP) 1998-09-03 WO disclosed